
About Jamp India Pharmaceuticals Private Limited
Data last updated:
Jamp India Pharmaceuticals Private Limited is a foreign private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Jamp Pharma Corporation, 1310 Rue Nobel, Boucherville, Quebec, Canada J4b 5H3.. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 20 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2017FTC099869. Its GSTIN is 24AAECJ1198H1ZK (Gujarat). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Alpeshkumar Thakkar and Raveesh Grover.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1207 To 1212 12th Floor Navratna Corporate Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹155.09 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹11.1 Cr (net margin 7.2%) and EBITDA of ₹21.11 Cr (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 32% over five years.
The company has about 515 employees on its provident fund (EPFO) records.
Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jamppharma.com.
Company details
Contact details
Jamp India Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is jamppharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1201 To 1204 & 1207 To 1212 12th Floor Navratna Corporate Park Ambli Bopal Roa, D, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Jamp India Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jamp India Pharmaceuticals is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Jamp India Pharmaceuticals Private Limited, buy the company report.
Financials of Jamp India Pharmaceuticals Private Limited
FY 2025 filings availableJamp India Pharmaceuticals Private Limited reported revenue of ₹155.09 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 19% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | ||||
| Net Profit Margin | 7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jamp India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jamp India Pharmaceuticals Private Limited
Jamp India Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alpeshkumar Thakkar Also directs: Nexcellife Research Labs Private Limited | Director | 30 Mar 2021 | 5 Years 7 Months | Current |
| Raveesh Grover | Director | 20 Nov 2017 | 8 Years 11 Months | Current |
| David Dimeo | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
| Marcandre Huot Also directs: Nexcellife Research Labs Private Limited | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Jamp India Pharmaceuticals Private Limited is audited by C. R. Sharedalal & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. R. Sharedalal & Co. | FY 2022 | 109943W |
Shareholding
The shareholding of Jamp India Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jamp India Pharmaceuticals Private Limited, buy the company report.
Legal cases
Jamp India Pharmaceuticals Private Limited has 8 court cases on record: 5 filed by Jamp India Pharmaceuticals, 3 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 3 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (A227) | Filed against the company by Medreich Limited | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against Jubilant Generics Ltd. | Disposed |
| Allahabad High Court | Court case (A227) | Filed by the company against Jubilant Generics Limited and 3 Others and 3 others | Disposed |
| High Court, UTTARPRADESH | Court case (COPL) | Filed against the company by V S International Private Limited | Disposed |
| High Court, UTTARPRADESH | Court case (COPL) | Filed by the company against Jubilant Generics Ltd. and 3 Others and 3 others | Disposed |
To see the full case history of Jamp India Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Jamp India Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2021 and 2024, listing 15 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Neurotech Computer Systems Pvt Ltd | |||
| Ortiv-Q3 Research Private Limited | |||
| Cleanchem Laboratories LLP |
To see the full MSME payment records of Jamp India Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Jamp India Pharmaceuticals Private Limited has a workforce of 515 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 515 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Jamp India Pharmaceuticals Private Limited, buy the company report.
GST
Jamp India Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECJ1198H1ZK | Gujarat | Active | 10 Jul 2018 |
| 24AAECJ1198H2ZJ | Gujarat | Active | 28 Mar 2023 |
| 36AAECJ1198H1ZF | Telangana | Active | 29 Mar 2020 |
To see the full GST registrations and return filing status of Jamp India Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jamp India Pharmaceuticals Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: David Dimeo was appointed as Director on 27 Sep 2024.
Frequently asked questions
Jamp India Pharmaceuticals is an active foreign private limited company based in Ahmedabad, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 20 November 2017 (9+ years old) and is registered under CIN U73100GJ2017FTC099869.
Jamp India Pharmaceuticals has 4 current directors:
- Alpeshkumar Thakkar - Director
- Raveesh Grover - Director
- David Dimeo - Director
- Marcandre Huot - Director
The latest financial statements of Jamp India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Jamp India Pharmaceuticals is 24AAECJ1198H1ZK, registered in Gujarat. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 24AAECJ1198H2ZJ (Gujarat), 36AAECJ1198H1ZF (Telangana).
The CIN (Corporate Identification Number) of Jamp India Pharmaceuticals is U73100GJ2017FTC099869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jamp India Pharmaceuticals has 8 court cases on record: 5 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.
Jamp India Pharmaceuticals was incorporated on 20 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
David Dimeo was appointed as Director on 27 Sep 2024. Marcandre Huot was appointed as Director on 27 Sep 2024. Alpeshkumar Thakkar ceased to be Additional Director on 24 Sep 2021. Jamp India Pharmaceuticals has 7 board changes on record in total.
Jamp India Pharmaceuticals has 4 MSME Form 1 returns on record between 2021 and 2024, listing 15 overdue payments to 7 micro and small suppliers. The latest return was filed on 20 May 2024.
Jamp India Pharmaceuticals can be reached through the website jamppharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Jamp India Pharmaceuticals is at 1201 To 1204 & 1207 To 1212 12th Floor Navratna Corporate Park Ambli Bopal Roa, D, Ahmedabad, Gujarat, India – 380058.

